SofWave Medical Ltd. (TLV:SOFW)
Israel
· Delayed Price · Currency is ILS · Price in ILA 4,330.00
-92.00 (-2.08%)
Apr 28, 2026, 5:24 PM IDT
SofWave Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Revenue | 87.64 | 59.65 | 50.32 | 35.63 | 21.84 | Upgrade
|
| Revenue Growth (YoY) | 46.92% | 18.55% | 41.22% | 63.15% | 408.95% | Upgrade
|
| Cost of Revenue | 21.68 | 14.32 | 12.83 | 9.3 | 5.63 | Upgrade
|
| Gross Profit | 65.96 | 45.34 | 37.48 | 26.33 | 16.21 | Upgrade
|
| Selling, General & Admin | 46.29 | 38.15 | 34.04 | 31.23 | 17 | Upgrade
|
| Research & Development | 12.8 | 10.77 | 11.43 | 12.44 | 8.21 | Upgrade
|
| Other Operating Expenses | - | - | - | -0 | - | Upgrade
|
| Operating Expenses | 59.09 | 48.92 | 45.47 | 43.67 | 25.21 | Upgrade
|
| Operating Income | 6.87 | -3.58 | -7.99 | -17.34 | -9 | Upgrade
|
| Interest Expense | -0.07 | -0.06 | -0.06 | -0.19 | -0.11 | Upgrade
|
| Interest & Investment Income | 0.67 | 0.7 | 0.78 | 0.33 | 0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.05 | 0.01 | 0.02 | -1.07 | 2.26 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.79 | -1.13 | -1 | -0.94 | -0.46 | Upgrade
|
| EBT Excluding Unusual Items | 5.74 | -4.06 | -8.26 | -19.21 | -7.28 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.14 | Upgrade
|
| Pretax Income | 5.74 | -4.06 | -8.26 | -19.21 | -7.15 | Upgrade
|
| Income Tax Expense | 0.25 | 0.49 | 0.02 | 0.32 | -0.32 | Upgrade
|
| Net Income | 5.49 | -4.55 | -8.28 | -19.53 | -6.83 | Upgrade
|
| Net Income to Common | 5.49 | -4.55 | -8.28 | -19.53 | -6.83 | Upgrade
|
| Shares Outstanding (Basic) | 35 | 34 | 34 | 34 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 40 | 34 | 34 | 34 | 23 | Upgrade
|
| Shares Change (YoY) | 15.83% | 0.53% | 0.26% | 44.98% | -45.50% | Upgrade
|
| EPS (Basic) | 0.15 | -0.13 | -0.24 | -0.57 | -0.29 | Upgrade
|
| EPS (Diluted) | 0.14 | -0.13 | -0.24 | -0.57 | -0.29 | Upgrade
|
| Free Cash Flow | 12.76 | -2.67 | -6.71 | -11.14 | -5.22 | Upgrade
|
| Free Cash Flow Per Share | 0.32 | -0.08 | -0.20 | -0.33 | -0.22 | Upgrade
|
| Gross Margin | 75.27% | 76.00% | 74.49% | 73.90% | 74.21% | Upgrade
|
| Operating Margin | 7.84% | -6.00% | -15.88% | -48.66% | -41.22% | Upgrade
|
| Profit Margin | 6.26% | -7.62% | -16.45% | -54.81% | -31.26% | Upgrade
|
| Free Cash Flow Margin | 14.56% | -4.48% | -13.34% | -31.27% | -23.90% | Upgrade
|
| EBITDA | 7.91 | -2.22 | -6.49 | -16.22 | -8.87 | Upgrade
|
| EBITDA Margin | 9.03% | -3.73% | -12.89% | -45.52% | -40.62% | Upgrade
|
| D&A For EBITDA | 1.04 | 1.36 | 1.51 | 1.12 | 0.13 | Upgrade
|
| EBIT | 6.87 | -3.58 | -7.99 | -17.34 | -9 | Upgrade
|
| EBIT Margin | 7.84% | -6.00% | -15.88% | -48.66% | -41.22% | Upgrade
|
| Effective Tax Rate | 4.34% | - | - | - | - | Upgrade
|
| Advertising Expenses | 8.4 | 8.23 | 4.68 | 3.85 | 1.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.